| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 18.317 | 26.397 | 31.488 | 34.630 | 37.143 | 38.781 | 50.563 | 70.519 |
| Total Income - EUR | - | - | 18.318 | 26.397 | 31.497 | 34.638 | 37.144 | 38.781 | 50.666 | 70.520 |
| Total Expenses - EUR | - | - | 10.968 | 16.897 | 23.440 | 23.100 | 20.562 | 23.510 | 27.044 | 28.481 |
| Gross Profit/Loss - EUR | - | - | 7.349 | 9.500 | 8.057 | 11.537 | 16.582 | 15.272 | 23.622 | 42.038 |
| Net Profit/Loss - EUR | - | - | 7.166 | 9.236 | 7.742 | 11.201 | 16.218 | 14.891 | 23.125 | 39.965 |
| Employees | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Cabinet Anli Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 19.800 | 19.437 | 15.248 | 13.089 | 11.431 | 9.341 | 7.314 | 5.455 |
| Current Assets | - | - | 3.084 | 4.857 | 9.806 | 22.752 | 9.041 | 14.873 | 17.744 | 39.459 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.410 | 2.162 | 7.022 | 474 | 440 | 10.861 | 3.320 | 29.120 |
| Cash | - | - | 1.675 | 2.694 | 2.785 | 22.277 | 8.601 | 4.012 | 14.424 | 10.339 |
| Shareholders Funds | - | - | 7.210 | 16.314 | 23.740 | 34.491 | 19.067 | 14.940 | 23.174 | 40.013 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 15.675 | 7.980 | 1.315 | 1.350 | 1.406 | 9.274 | 1.884 | 4.901 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Anli Med Srl